joint venture

Through the JV and strategic partnership, the companies aim to provide precision diagnostic products and services to Hong Kong, Macau, South Korea, and Southeast Asia.

The firms will jointly invest in establishing a joint venture company in China, and Autobio has also invested €10 million in Mobidiag.

Through their joint venture, Berry and Prenetics aim to offer a range of direct-to-consumer genetic testing services to the Chinese market.

The two firms will provide €14M ($16.2 million) of equity funding to commercialize the Idylla platform in the Chinese market.

The planned joint venture with Beijing Zishan Health Consultancy is aimed at bringing Genetic Technologies' genomic tests to the Chinese market.

A new company will be established to develop a service platform using blockchain technology for medical services and personalized health management.

The partners plan to apply genomics to traditional Chinese medicine.

The companies formed the joint venture in 2008 to commercialize BioMérieux's IVD products and medical instruments in Japan.

The new company will develop microbiome diagnostics for multiple indications including inflammatory bowel disease and liver disorders.